Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
01/2011
01/06/2011WO2011002067A1 Heterocyclic compound and use thereof
01/04/2011US7863456 Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acid
01/04/2011CA2404128C Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
12/2010
12/29/2010WO2010151672A2 Amino acid derived ureas
12/29/2010WO2010148650A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
12/29/2010WO2010148649A1 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
12/29/2010EP2266555A2 Compounds with antiparasitic activity and medicines containing same
12/29/2010EP2265594A2 Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
12/28/2010US7858211 Organic electroluminescent device
12/23/2010WO2010091876A3 Small molecule bradykinin b1 receptor antagonists
12/22/2010EP2262782A1 Novel aminomethyl benzene derivatives
12/22/2010EP2041100B1 Substituted 5- phenylamino- 1, 3, 4-oxadiaz0l-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase
12/22/2010CN101925366A Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
12/21/2010US7855220 sodium channel and calcium channel inhibitors, such as 2-Indol-1-yl-N-[5-(thiazol-2-ylsulfamoyl)-naphthalen-1-yl]-propionamide, used as analgesics or for the treatment of neurodegenerative disorders, anxiety, depression, arrhythmia, ataxia, multiple sclerosis, irritable bowel syndrome or incontinence
12/16/2010WO2010115751A3 Oxadiazole derivatives
12/16/2010US20100317854 Novel aminodicarboxylic acid derivatives having pharmaceutical properties
12/16/2010US20100317653 Oxadiazole derivatives as dgat inhibitors
12/16/2010US20100317582 Novel cyclic hydrocarbon compounds for the treatment of diseases
12/15/2010EP2260028A2 Selective androgen receptor modulators
12/14/2010US7851636 {2-[3-Cyclohexyl-3-(trans-4-propoxy-cyclohexyl)-ureido]-thiazol-5-ylsulfanyl}-acetic acid; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial; antidiabetic agents
12/14/2010US7851493 Phenyl-1,2,4-oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
12/14/2010CA2535199C Amide derivative
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/08/2010EP2259068A2 Capture compounds and methods for analyzing the proteome
12/08/2010EP2258700A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
12/08/2010CN1821243B Substituted pyridine M1 receptor excitomotor, its preparing process and its use
12/08/2010CN101910141A A novel alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
12/07/2010US7847100 enzyme ihibitors such as 3-{5-[(1R)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide, used for treating neurodegenerative diseases
12/07/2010US7846956 Malononitrile compound as pesticides
12/02/2010WO2010136493A1 Substituted aminopropionic derivatives as neprilysin inhibitors
12/02/2010US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors
12/02/2010US20100305104 Oxadiazole Diaryl Compounds
12/02/2010US20100305100 Methods for treating hepatitis c
12/02/2010US20100305056 Cysteine protease inhibitors for the treatment of parasitic disease
12/02/2010CA2763572A1 Substituted aminopropionic derivatives as neprilysin inhibitors
11/2010
11/30/2010CA2450076C Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or a diagnostic agent and pharmaceutical preparations containing said compounds
11/25/2010US20100298168 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
11/25/2010US20100297250 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds
11/24/2010EP2253328A1 Cycloalkyl inhibitors of potassium channel function
11/24/2010EP2252590A1 Substituted sulfonic acid amide compounds
11/24/2010EP1583972B1 Methods for identifying drug non-target proteins
11/24/2010CN101891698A 3,4-di(3',5'-dinitryl-4'-methyl phenyl) furoxan compound
11/24/2010CN101891697A Alpha, beta-unsaturated ketone compound containing 1,2,4-oxadiazoles heterocycle
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010US7838023 Ethanamine, 2-L[5-oxido-4-phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy]-N,N-bis[2-[[5-oxido-4-(phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy]ethyl]-; cardiovascular diseases; inhibiting platelet aggregation, platelet adhesion caused by the exposure of blood to a medical device; abnormal cell proliferation
11/18/2010WO2010130063A1 The little molecule compound which used for promoting the stem cells hyperplasia and the use thereof
11/18/2010US20100292283 Novel phenyl-acetamide and phenyl-propionamide derivatives useful as potassium channel modulators
11/18/2010US20100292282 Synthesis and crystalline forms of cb-1 antagonist/inverse agonist
11/18/2010US20100292274 Haloalkyl heteroaryl benzamide compounds
11/18/2010CA2761876A1 Haloalkyl heteroaryl benzamide compounds
11/17/2010EP2251333A1 Biphenyl derivatives as P-38 kinase inhibitors
11/17/2010CN101885684A Aromatic acid pro-drug with nitrogen monoxide donor, and preparation method and application thereof
11/16/2010US7834039 Oxadiazole compounds
11/11/2010WO2010128156A1 2,1,3-benzoxadiazol derivatives for the inhibition of influenza a and b virus and respiratory syncytial virus replication
11/11/2010WO2010105179A3 Inhibitors of beta-secretase
11/11/2010US20100286149 Novel benzamide derivatives useful as potassium channel modulators
11/09/2010US7829639 Composition for conductive layers in electronic devices
11/04/2010WO2010083404A3 Linked myc-max small molecule inhibitors
11/04/2010US20100280083 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
11/03/2010EP2246338A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
10/2010
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2009140089A8 Sulfone compounds which modulate the cb2 receptor
10/28/2010US20100273763 Organometallic complexes as therapeutic agents
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/26/2010US7820674 Especially 1-(5-((R)-2-Amino-1-phenylpropan-2-yl)-1,3,4-oxadiazol-2-yl)methyl)-4-butylpiperazine-2,3-dione or derivatives; amyloid precursor protein-cleaving enzyme
10/21/2010WO2010120741A1 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
10/21/2010US20100267775 Oxadiazolidinedione compound
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010CA2758587A1 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
10/20/2010EP2241558A1 Oxadiazole derivatives
10/20/2010EP1951653B1 Salicylic acid derivatives
10/20/2010CN101863852A Aromatic diamine containing 1,3,4-oxadiazole heterocyclic structure and preparation method thereof
10/14/2010WO2010115751A2 Oxadiazole derivatives
10/14/2010US20100261767 Oxadiazole derivatives for use as s1p1 agonists in the treatment of autoimmune and inflammatory disorders
10/14/2010US20100261673 Antibacterial compounds and methods of using same
10/14/2010CA2755918A1 Oxadiazole derivatives
10/13/2010EP2238131A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
10/12/2010US7812040 Histamine-3 receptor antagonists
10/12/2010US7812024 such as (4R,11aR)-4-methyl-1,2,3,4,11,11a-hexahydropyrazino[1,2-b]isoquinolin-6-one, used for the treatment of obesity, diabetes, atherosclerosis, dyslipidemia, anxiety, depression, psychosis, schizophrenia, sleep, sexual, obsessive compulsive and gastrointestinal disorders
10/12/2010US7811675 Luminance, high purity, low cost, and good thermal stability; as emitters for polymeric light-emitting diodes (PLEDs)
10/07/2010WO2010112461A1 Oxadiazole derivatives
10/07/2010US20100256115 Inhibitors of iap
10/07/2010CA2755928A1 Oxadiazole derivatives
10/06/2010EP2236495A1 New salts for adding angiotensin conversion enzyme inhibitors to NO-donor acids, method of preparing same and pharmaceutical compositions containing them
10/06/2010EP2234993A1 Bis- (sulf onylamino) derivatives for use in therapy
10/06/2010EP2234991A1 Romp-polymerizable electron transport materials based on a bis-oxadiazole moiety
10/06/2010EP2234954A1 Tetrasubstituted benzenes
10/06/2010CN101851216A Oxadiazole derivative, and electronic device, and lighting device using oxadiazole derivative
10/06/2010CN101851215A Method for catalyzing and synthesizing 3,4-dinitrofurazan by utilizing1-butyl-3-methylimidazole tungstate
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/05/2010US7807701 Dibenzylamine compounds and pharmaceutical use thereof
10/05/2010US7807669 Peroxisome proliferator-activated receptor type gamma (PPAR- gamma) modulators such as (S)-3-{3'-[(benzoylmethylamino)methyl]biphenyl-4-yl}-2-(1-methyl-3-oxo-3-phenylpropenylamino)propionic acid, suited for use in dermatology, immunology, cardiovascular diseases and/or hyperlipemia
09/2010
09/30/2010WO2010008831A3 Compounds and methods for modulating g protein-coupled receptors
09/30/2010US20100249349 Novel Polymers
09/30/2010US20100249197 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
09/30/2010US20100249123 Novel benzamide derivatives as modulators of the follicle stimulating hormone
09/30/2010US20100248264 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/30/2010US20100244673 Oxadiazole Derivative, and Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device Using Oxadiazole Derivative
09/30/2010US20100244669 Oxadiazole derivative, light-emitting element, display device, lighting device, and electronic device
09/29/2010EP2233473A1 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as S1P1 receptor agonists, immunosuppresssive and anti-inflammatory agents
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 72